Q & A with Karen Tashima, MD – New Direct-Acting, Antiviral Agents Offer Therapeutic Revolution for Hepatitis C Virus Infection

Mary Korr

首页> 外文期刊>Medicine and Health - Rhode Island >Q & A with Karen Tashima, MD – New Direct-Acting, Antiviral Agents Offer Therapeutic Revolution for Hepatitis C Virus Infection

【24h】

Q & A with Karen Tashima, MD – New Direct-Acting, Antiviral Agents Offer Therapeutic Revolution for Hepatitis C Virus Infection

机译：与医学博士Karen Tashima的问答-新型直接作用抗病毒药为丙型肝炎病毒感染带来治疗革命

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Medicine and Health - Rhode Island》 |2014年第7期|共页
作者
Mary Korr;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医药、卫生;
关键词
入库时间 2022-08-18 11:27:01

相似文献

外文文献
中文文献
专利

1. Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection [J] . Chun-Jen Liu, Yu-Jen Fang, Tung-Hung Su, Open Forum Infectious Diseases . 2017,第1期

机译：接受慢性丙型肝炎病毒感染的无干扰素直接作用抗病毒药物的患者中的乙肝病毒激活
2. Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation [J] . Elmasry Sandra, Wadhwa Sanya, Bang Bo-Ram, Gastroenterology . 2017,第3期

机译：检测肝脏移植后患者持续发生抗病毒剂的持续病毒性反应的患者患者患者
3. More Sensitivity Analysis of Share 35, Human Immunodeficiency Virus Co-infection, Delist, Hospital Cost on Cost Effectiveness of Direct-Acting Antiviral Agents for Liver Transplant Hepatitis C Virus Patients [J] . Xibei Liu, Hyun Phil Shin, Ji Won Yoo Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2017,第12期

机译：肝移植丙型肝炎病毒患者直接作用抗病毒试剂的肝病35，人类免疫缺陷病毒有效，劳动力，医院成本对肝脏抗病毒剂的成本效力的更多敏感性分析
4. Genome-wide prediction and analysis of siRNA as potential antiviral agent against Hepatitis-C virus [C] . Divya Khanna, Vikas Kaushik, Atul Kumar Upadhyay International Conference on Bioinformatics and Systems Biology . 2018

机译：siRNA作为丙型肝炎病毒潜在抗病毒药物的全基因组预测和分析
5. Analyzing the Impact of the CMS Guidance on Assuring Access to Hepatitis C Virus (HCV) Drugs on Utilization of Direct-Acting Antiviral (DAA) Agents [D] . Ferrell, Kelli Walker. 2017

机译：分析CMS指南对确保获得丙型肝炎病毒（HCV）药物对直接作用抗病毒（DAA）药物利用的影响
6. Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection [O] . Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, 2017

机译：接受慢性丙型肝炎病毒感染的无干扰素直接作用抗病毒药物的患者中的乙肝病毒激活
7. Direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution? [O] . Alain Braillon 2015

机译：直效抗病毒药物和丙型肝炎病毒：治疗革命？
8. Guidance for Industry Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Agents for Treatment [R] . 2010

机译：工业慢性丙型肝炎病毒感染指南：开发直接作用的抗病毒药物进行治疗

Q & A with Karen Tashima, MD – New Direct-Acting, Antiviral Agents Offer Therapeutic Revolution for Hepatitis C Virus Infection

著录项

相似文献

相关主题

期刊订阅